PALLADIA DIN 02338564
Status: Marketed
Holder: ZOETIS CANADA INC
Health Canada record
| Active ingredient(s) | TOCERANIB (TOCERANIB PHOSPHATE) 50 MG |
|---|
| Dosage form | Tablet |
|---|
| Route | Oral |
|---|
| Schedule | PRESCRIPTION |
|---|
| Class | Veterinary |
|---|
| ATC | |
|---|
| Original market date | 01-May-2010 |
|---|
| Current status date | 03-Jul-2015 |
|---|
| Source | Health Canada DPD |
|---|
Establishment licence of the holder
Zoetis Canada Inc — licence 102076, currently licensed, last inspection rating C (2023-10-05).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing TOCERANIB (TOCERANIB PHOSPHATE)
| DIN | Product | Company | Form | Strength | Status |
|---|
| 02338548 | PALLADIA | ZOETIS CANADA INC | Tablet | TOCERANIB (TOCERANIB PHOSPHATE) 10 MG | Marketed |
| 02338556 | PALLADIA | ZOETIS CANADA INC | Tablet | TOCERANIB (TOCERANIB PHOSPHATE) 15 MG | Marketed |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|
| 15326 | 2014-02-26 | New Drug Submission (NDS) | TRANSFER OF DRUG IDENTIFICATION NUMBER (DIN) HOLDER |
| 10824 | 2009-12-01 | New Drug Submission (NDS) | |
Request a quote for PALLADIA
How to read a Canadian DIN record